Medtronic (MDT) Short-Term Debt issuances (2014 - 2026)

Medtronic has disclosed Short-Term Debt issuances across 13 years of filings, most recently posting -$1.2 billion for Q1 2026.

• Short-Term Debt issuances for Q1 2026 came in at -$1.2 billion, down 22.53% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.2 billion (up 223.44% YoY), and the FY2024 annual result was $1.1 billion, down 53.02% from the prior year.
• Short-Term Debt issuances came in at -$1.2 billion for Q1 2026 at Medtronic, down from $753.0 million in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $2.3 billion in Q4 2022 to a low of -$1.7 billion in Q1 2023.
• The 5-year median for Short-Term Debt issuances is $500.0 million (2023), against an average of $256.1 million.
• Across the five-year window, Short-Term Debt issuances sank 224.8% in 2024 and soared 1598.41% in 2025, its largest moves.
• Medtronic's Short-Term Debt issuances stood at $2.3 billion in 2022, then plunged by 64.05% to $821.0 million in 2023, then plunged by 32.16% to $557.0 million in 2024, then surged by 35.19% to $753.0 million in 2025, then plunged by 263.21% to -$1.2 billion in 2026.
• The last three Short-Term Debt issuances figures came in at -$1.2 billion (Q1 2026), $753.0 million (Q4 2025), and $649.0 million (Q3 2025), per Business Quant data.